Mylan-Sumatriptan (sumatriptan succinate) is indicated for the acute treatment of migraine attacks with or without aura. Mylan-Sumatriptan is not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic, basilar, or ophthalmoplegic migraine (see CONTRAINDICATIONS).